Skip to content
healthcare.dev

HERZUMA

NDC 63459-303, TRASTUZUMAB, injection, powder, lyophilized, for solution, from Cephalon, Inc..

Product NDC
63459-303
Status
Listed
Labeler
Cephalon, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761091
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63459-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB150 mg/7.15mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
63459-303-43634590303431 VIAL, SINGLE-DOSE in 1 CARTON (63459-303-43) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae71c003-883a-4cd8-ad50-e8cc9a54e971
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63459-303

Use it

Look up 63459-303 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63459-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63459-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.